Barclays PLC Marker Therapeutics, Inc. Transaction History

Barclays PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$1.68 - $2.88 $5,688 - $9,751	-3,386 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.88 - $3.56 $6,365 - $12,054	3,386 New	3,386 $9,000
Q3 2020 Nov 12, 2020	SELL	$1.5 - $2.2 $37,942 - $55,649	-25,295 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.69 - $2.79 $42,748 - $70,573	25,295 New	25,295 $53,000
Q1 2020 May 13, 2020	SELL	$1.59 - $3.35 $43,093 - $90,795	-27,103 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$2.68 - $4.85 $72,636 - $131,449	27,103 New	27,103 $78,000
Q3 2019 Nov 14, 2019	SELL	$4.1 - $9.0 $114,668 - $251,712	-27,968 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$5.15 - $7.92 $528,523 - $812,797	-102,626 Reduced 78.58%	27,968 $221,000
Q1 2019 May 15, 2019	SELL	$5.1 - $6.71 $150,577 - $198,112	-29,525 Reduced 18.44%	130,594 $862,000
Q4 2018 Feb 14, 2019	BUY	$4.2 - $9.74 $672,499 - $1.56 Million	160,119 New	160,119 $889,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $259M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.